Literature DB >> 22170021

Severe anorexia nervosa: outcomes from a medical stabilization unit.

Jennifer L Gaudiani1, Allison Lee Sabel, Margherita Mascolo, Philip S Mehler.   

Abstract

OBJECTIVE: We report data from the medical stabilization and refeeding of patients with severe anorexia nervosa admitted over a 15-month period.
METHOD: Through chart review and computerized data collection, we evaluated demographic and clinical data from 25 consecutive patients admitted to our medical stabilization unit from October 2008 to January 2010.
RESULTS: In this adult-patient population with a median body mass index (BMI) of 13.1 kg/m(2) (interquartile range, 11.0-14.4), 44% developed hypoglycemia, 76% had abnormal liver function, 83% had abnormal bone density, 45% developed refeeding hypophosphatemia, and 92% were hypothermic. Severe liver function abnormality predicted the development of hypoglycemia (p = 0.02, OR 9.78, CI: 1.55-61.65). No clinical features predicted hypophosphatemia, including admission BMI (p = 0.19), serum glucose level (p = 0.21), elevated liver function tests (p = 0.39 for AST), or initial amount of kilocalories consumed (p = 0.06). DISCUSSION: Patients with the most severe cases of anorexia nervosa have a high prevalence of serious medical complications during initial refeeding.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22170021     DOI: 10.1002/eat.20889

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  26 in total

1.  Refeeding hypophosphatemia in hospitalized adolescents with anorexia nervosa: a position statement of the Society for Adolescent Health and Medicine.

Authors: 
Journal:  J Adolesc Health       Date:  2014-09       Impact factor: 5.012

2.  Inpatient medical stabilization for adolescents with eating disorders: patient and parent perspectives.

Authors:  Terrill Bravender; Hannah Elkus; Hannah Lange
Journal:  Eat Weight Disord       Date:  2016-04-06       Impact factor: 4.652

3.  Common and Emergent Oral and Gastrointestinal Manifestations of Eating Disorders.

Authors:  Jessica A Lin; Elizabeth R Woods; Elana M Bern
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-04

Review 4.  Hepatic Complications of Anorexia Nervosa.

Authors:  Elissa Rosen; Neeru Bakshi; Ashlie Watters; Hugo R Rosen; Philip S Mehler
Journal:  Dig Dis Sci       Date:  2017-09-20       Impact factor: 3.199

5.  Partial rescue of retinal function in chronically hypoglycemic mice.

Authors:  Yumiko Umino; Nicolas Cuenca; Drew Everhart; Laura Fernandez-Sanchez; Robert B Barlow; Eduardo Solessio
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

6.  Prevalence of abnormal liver function tests and comorbid psychiatric disorders among patients with anorexia nervosa and eating disorders not otherwise specified in the anorexia nervosa DSM-IV criteria.

Authors:  Kye Hock Robin Goh; Ee Lian Lee
Journal:  Singapore Med J       Date:  2015-09       Impact factor: 1.858

Review 7.  A systematic review of approaches to refeeding in patients with anorexia nervosa.

Authors:  Andrea K Garber; Susan M Sawyer; Neville H Golden; Angela S Guarda; Debra K Katzman; Michael R Kohn; Daniel Le Grange; Sloane Madden; Melissa Whitelaw; Graham W Redgrave
Journal:  Int J Eat Disord       Date:  2015-12-12       Impact factor: 4.861

8.  Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease?

Authors:  Michael A Flierl; Jennifer L Gaudiani; Allison L Sabel; Carlin S Long; Philip F Stahel; Philip S Mehler
Journal:  Ann Gen Psychiatry       Date:  2011-05-04       Impact factor: 3.455

9.  Enteral nutrition for feeding severely underfed patients with anorexia nervosa.

Authors:  Maria Gabriella Gentile
Journal:  Nutrients       Date:  2012-09-14       Impact factor: 5.717

10.  Metabolic and nutritional needs to normalize body mass index by doubling the admission body weight in severe anorexia nervosa.

Authors:  Maria Gabriella Gentile; Chiara Lessa; Marina Cattaneo
Journal:  Clin Med Insights Case Rep       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.